Bandaram Pharma Packtech Subsidiary Secures Work Orders from Telangana Government Worth Rs 27.7 Crores
Bandaram Pharma Packtech Limited's material subsidiary, VSR Paper and Packaging Limited, has secured two work orders from the Government of Telangana. The contracts involve the printing and distribution of Text Books with paper and lamination for the academic year 2026-27.The awarded business totals Rs 27,70,50,780 across both contracts. These orders are designated for domestic entities, and the execution period is set between June and August 2026.
The details of the two work orders granted by the Government of Telangana are as follows:
| Particulars | Work Order 1 | Work Order 2 |
|---|---|---|
| Number of Text Books | 32,75,336 | 99,554 |
| Total Order Worth (in Rs.) | 26,78,66,680 | 91,84,100 |
The contracts specify that the books must be available for sale starting from June 1, 2026.
This successful contract acquisition is by VSR Paper and Packaging Limited, a material subsidiary of Bandaram Pharma Packtech Limited. The entity awarding the orders, Government of Telangana, confirmed no interest held by the promoter or the promoter group in the awarded contracts. Furthermore, the orders do not fall within related party transactions.
The work order pertains to the printing and distribution of Text Books with paper and lamination for the academic year 2026-27. This contract value is consistent with and corrects a previous figure reported regarding the scope of the business opportunity.
Stock Price Movement
Bandaram Pharma Packtech Ltd shares settled on Thursday at ₹27.50, dropping 2.14% in the close of trade. The stock experienced intraday volatility, trading between a low of ₹27.25 and a high of ₹29.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.